RxDoctor Payments Data

Melissa Benham, NP

Family · Springboro, OHNPI 1184217408

Payments from drug & device makers

$4,652in general payments, 2019–2025

Across 391 payments — averaging $11.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$515
  • Novo Nordisk$482
  • Corium, LLC$303
  • Nestle Healthcare Nutrition Inc.$224
  • Merck$134
  • plus $729 from 16 others

What the payments were for

  • Food & beverage$4,652100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,652 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$14,123
Medicare patients
43
Services billed
206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide18$25,536
JardianceEmpagliflozin17$21,930
Atorvastatin Calcium85$642
Duloxetine Hcl22$430
Bupropion XlBupropion Hcl20$348
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$343
Gabapentin17$342
Albuterol Sulfate HfaAlbuterol Sulfate23$333
Pantoprazole Sodium22$286
Omeprazole26$273
Levothyroxine Sodium59$249
Tamsulosin Hcl12$215
Losartan Potassium17$197
Tramadol Hcl13$159
Metformin Hcl24$157

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus$482$25,53618 claims
Boehringer IngelheimJardiance$66$21,93017 claims
Almatica Pharma LLCSertraline Hcl$32$9522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.

Other family in Springboro

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →